Free Perinatal Education ECHO Series Now Available
May 21, 2026
The Minnesota Perinatal Quality Collaborative (MNPQC) is offering a free, virtual ECHO series on perinatal education.
HHS Continues to Work on Transition of Paxlovid to Commerical Market
October 19, 2023
The U.S. Department of Health and Human Services (HHS) announced on October 13 that HHS and Pfizer have reached an agreement that will transition Paxlovid, the COVID-19 therapeutic, to the commercial market.
Preparations for the transition will begin next month, but Paxlovid will remain available for ordering from HHS through December 15.
Individuals on Medicare and Medicaid will access free government-procured Paxlovid through a patient assistance program through the end of 2024. Individuals who are uninsured or underinsured will access free government-procured Paxlovid through a patient assistance program through the end of 2028.
Pfizer will operate a copay assistance program for those with private insurance through 2028. Pfizer has agreed to replenish any government-procured product that is about to expire with up-to-date product and has also agreed to provide HHS with a stockpile of 1 million treatment courses for future COVID-19 surges.
HHS is working on additional details, particularly about the patient assistance program. Pfizer has not yet announced cost details for Paxlovid, but there is media speculation that the cost will be several times the current government negotiated price of $530/course.
Latest News
First Cohort of Medical School Students Celebrated in St. Cloud
May 21, 2026
As a salute to the inaugural class of the University of Minnesota Medical School CentraCare Regional Campus St. Cloud, the MMA held an open house on May 18 at its Board Chair’s home in Sartell.
MMA and More Than 400 Orgs Urge Federal Funding for Gun Violence Prevention Research
May 21, 2026
The MMA signed onto a letter to Congress’ Committee on Appropriations on May 18 urging leaders to include funding in the 2027 budget for gun violence prevention research.